text
"['\n3. 타법인출자 현황\n[2008. 12. 31 현재]\n(단위 : 주, 백만원, %)\n구분\n계정과목\n법인명또는종목명\n출자목적\n기초잔액\n증가(감소)내역\n기말잔액\n피출자법인의최근사업연도당기순이익\n비고\n수량\n지분율\n장부가액\n수량\n취득(처분)가액\n수량\n지분율\n장부가액\n국내\n출자금(비상장)\n(주)BRI\n지배\n200\n100\n200\n2,000,\n2,000\n2,200\n50\n2,200\n-\n2007.11.20설립\n해외\n출자금(비상자)\nDong-IL Interlining\n지배\n-\n100\n432\n-\n-\n-\n100\n432\n-379\n-\n출자금(비상장)\nVGX Pharmaceuticals\n최대주주에 출자\n300\n0.67\n1,414\n-\n-\n300\n0.67\n1,414\n-\n-\n출자금(비상장)\nVGXI, Inc.\n지배\n-\n-\n-\n500\n4,002\n500\n100\n4,002\n-2,225\n2008.05.15설립\n합 계\n500\n-\n2,046\n2,500\n6,002\n3,000\n-\n8,048\n-2,604\n-\n']"
